Genmab | GEN - Fremdkapital





Fremdkapital Veränderung Datum
Agios Pharmaceuticals USD 1.06M 0 2022-09
Almirall EUR 303.77M 21.04M 2026-06
Amgen USD 51.86B 27M 2026-06
argenx SE USD 36M 432K 2026-06
AstraZeneca USD 26.01B 46M 2026-06
Bayer EUR 31.16B 480M 2026-06
BioMarin Pharmaceutical USD 3.53B 2.1B 2026-06
Demant DKK 13.13B 5.86B 2026-06
Fresenius Medical Care EUR 5.82B 83.04M 2026-06
Genmab DKK 4.96B 28M 2026-06
GlaxoSmithKline GBP 13.95B 65M 2026-06
GN Store Nord DKK 8.1B 790M 2026-03
GRIFOLS EUR 7.17B 1.91B 2026-06
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Insmed USD 543.51M 1.3M 2026-06
Lakefront Biotherapeutics EUR 4.77M 78K 2026-06
Lonza CHF 3.88B 323M 2025-12
Merck EUR 11.21B 406M 2026-06
Novartis USD 37.49B 42M 2026-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Sanofi EUR 14.65B 806M 2026-06
UCB EUR 2.18B 634M 2025-12